What does high homocysteine mean?

High homocysteine levels indicate increased risk for cardiovascular disease, stroke, and other health issues, often caused by B-vitamin deficiencies or genetic factors. Levels above 15 μmol/L require attention through dietary changes, supplementation, and regular monitoring.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Homocysteine and Its Role in Your Body

Homocysteine is an amino acid that your body produces naturally during the breakdown of methionine, an essential amino acid found in protein-rich foods like meat, fish, and dairy products. Under normal circumstances, your body efficiently converts homocysteine into other beneficial compounds through a process called methylation, which requires adequate levels of B vitamins, particularly folate (B9), vitamin B12, and vitamin B6.

When this conversion process doesn't work properly, homocysteine accumulates in your bloodstream, potentially damaging the inner lining of your arteries and promoting blood clot formation. This accumulation can signal underlying health issues or nutritional deficiencies that need attention.

What Are Normal vs. High Homocysteine Levels?

Understanding where your homocysteine levels fall on the spectrum is crucial for assessing your health risk. Medical professionals use specific ranges to categorize homocysteine levels and determine appropriate interventions.

Homocysteine Level Categories and Clinical Significance

Homocysteine LevelCategoryHealth RiskRecommended Action
Below 10<10 μmol/LOptimalLow cardiovascular riskMaintain healthy lifestyle
10-1510-15 μmol/LBorderlineSlightly increased riskDietary modifications, monitor annually
15-3015-30 μmol/LModerately elevatedModerate cardiovascular riskB vitamin supplementation, lifestyle changes
30-10030-100 μmol/LSeverely elevatedHigh risk for vascular diseaseAggressive treatment, investigate causes
Above 100>100 μmol/LVery severely elevatedVery high risk, possible genetic disorderSpecialist referral, genetic testing

Homocysteine levels should be interpreted alongside other cardiovascular risk factors and clinical symptoms.

While laboratories may have slightly different reference ranges, most experts agree that optimal homocysteine levels should be below 10 μmol/L for the best cardiovascular protection. Levels between 10-15 μmol/L are considered borderline and may warrant dietary modifications and closer monitoring.

Age and Gender Considerations

Homocysteine levels naturally vary based on age and gender. Men typically have higher levels than premenopausal women, likely due to the protective effects of estrogen. After menopause, women's homocysteine levels often increase and may match or exceed those of men. Children and adolescents generally have the lowest levels, which gradually increase with age.

Health Risks Associated with Elevated Homocysteine

High homocysteine levels, a condition known as hyperhomocysteinemia, significantly increase your risk for various serious health conditions. Research has consistently shown that elevated homocysteine acts as an independent risk factor for cardiovascular disease, meaning it increases your risk regardless of other factors like cholesterol levels or blood pressure.

Cardiovascular Disease

The most well-established risk associated with high homocysteine is cardiovascular disease. Elevated levels can damage the endothelium (inner lining of blood vessels), promote atherosclerosis (plaque buildup in arteries), and increase the likelihood of blood clots. Studies show that for every 5 μmol/L increase in homocysteine, the risk of coronary heart disease increases by approximately 20%.

Stroke and Neurological Conditions

High homocysteine levels are associated with an increased risk of both ischemic and hemorrhagic stroke. Additionally, elevated levels have been linked to cognitive decline, dementia, and Alzheimer's disease. The exact mechanisms aren't fully understood, but homocysteine may damage brain blood vessels and contribute to the formation of amyloid plaques.

Other Health Complications

  • Deep vein thrombosis and pulmonary embolism
  • Pregnancy complications including preeclampsia and recurrent miscarriage
  • Osteoporosis and increased fracture risk
  • Age-related macular degeneration
  • Certain types of cancer, though research is ongoing

Common Causes of High Homocysteine

Understanding what drives homocysteine levels up is essential for developing an effective treatment strategy. The causes can be broadly categorized into nutritional deficiencies, genetic factors, lifestyle choices, and medical conditions.

Nutritional Deficiencies

The most common cause of elevated homocysteine is inadequate intake or absorption of B vitamins. Folate deficiency is particularly prevalent, especially in populations that don't consume fortified foods or adequate amounts of leafy green vegetables. Vitamin B12 deficiency is common in older adults, vegetarians, vegans, and people with digestive disorders that impair absorption. Vitamin B6 deficiency, while less common, can also contribute to elevated levels.

Genetic Factors

Genetic mutations affecting enzymes involved in homocysteine metabolism can lead to elevated levels. The most common is a mutation in the MTHFR gene (methylenetetrahydrofolate reductase), which affects up to 40% of the population. People with two copies of the C677T mutation may have homocysteine levels 20-30% higher than those without the mutation. Regular monitoring of your cardiovascular biomarkers can help identify if you're at increased risk due to genetic factors.

Lifestyle and Medical Factors

  • Chronic kidney disease, which impairs homocysteine clearance
  • Hypothyroidism and other hormonal imbalances
  • Certain medications including methotrexate, anticonvulsants, and metformin
  • Excessive alcohol consumption
  • Smoking and high coffee intake
  • Sedentary lifestyle and obesity

Symptoms and Detection of High Homocysteine

One of the challenges with high homocysteine is that it typically doesn't cause noticeable symptoms on its own. Most people discover they have elevated levels only through blood testing, often after experiencing a cardiovascular event or during routine health screening. This silent nature makes regular monitoring particularly important for those at risk.

When symptoms do occur, they're usually related to the underlying cause or the complications of long-term elevation. These may include fatigue and weakness from B vitamin deficiencies, chest pain or shortness of breath from cardiovascular disease, or cognitive changes from neurological effects.

Testing for Homocysteine

A simple blood test can measure your homocysteine levels. The test is typically performed after an overnight fast, as eating can temporarily affect levels. Your healthcare provider may recommend testing if you have a family history of heart disease, have experienced unexplained blood clots, or have risk factors for B vitamin deficiencies.

For comprehensive cardiovascular risk assessment, homocysteine testing is often combined with other markers like cholesterol panels, inflammatory markers, and metabolic indicators. This holistic approach provides a more complete picture of your heart health status.

Strategies to Lower High Homocysteine Levels

The good news is that high homocysteine levels can often be effectively lowered through targeted interventions. The approach typically combines dietary modifications, supplementation when necessary, and lifestyle changes.

Dietary Interventions

Increasing your intake of B vitamins through food is the first line of defense. Focus on incorporating these nutrient-rich foods into your daily diet:

  • Folate-rich foods: leafy greens, legumes, citrus fruits, fortified grains
  • B12 sources: fish, meat, poultry, eggs, dairy products, fortified plant milks
  • B6 foods: chickpeas, tuna, salmon, chicken breast, potatoes, bananas
  • Betaine sources: beets, spinach, whole grains, shellfish

Supplementation Protocols

When dietary changes alone aren't sufficient, supplementation can be highly effective. The typical protocol includes folic acid (400-1000 mcg daily), vitamin B12 (500-1000 mcg daily), and vitamin B6 (10-50 mg daily). Some individuals, particularly those with MTHFR mutations, may benefit from methylated forms of these vitamins, such as methylfolate and methylcobalamin.

Lifestyle Modifications

Beyond nutrition, several lifestyle changes can help normalize homocysteine levels. Regular physical activity improves methylation processes and cardiovascular health. Limiting alcohol intake is crucial, as alcohol interferes with B vitamin absorption and metabolism. Quitting smoking and reducing coffee consumption to moderate levels (2-3 cups daily) can also help. Managing stress through meditation, yoga, or other relaxation techniques may provide additional benefits.

Monitoring Your Progress and Long-term Management

Successfully managing homocysteine levels requires ongoing monitoring and adjustment of your treatment plan. After initiating dietary changes or supplementation, retesting is typically recommended after 6-12 weeks to assess response. Once levels normalize, annual testing may be sufficient unless you have additional risk factors.

It's important to work with healthcare providers who understand the significance of homocysteine in overall health. They can help you interpret your results in the context of your complete health picture, including other cardiovascular risk factors, genetic predispositions, and lifestyle factors. Regular comprehensive testing that includes homocysteine along with other key biomarkers provides the most complete assessment of your cardiovascular and metabolic health.

Taking Action for Better Health

High homocysteine levels represent a modifiable risk factor for serious health conditions. While the discovery of elevated levels can be concerning, it's important to remember that this condition is highly treatable in most cases. Through a combination of proper nutrition, targeted supplementation when needed, and healthy lifestyle choices, most people can successfully lower their homocysteine levels and reduce their risk of associated health problems.

The key is to take a proactive approach to your health by getting tested, understanding your results, and working with knowledgeable healthcare providers to develop a personalized treatment plan. With consistent effort and regular monitoring, you can optimize your homocysteine levels and support your long-term cardiovascular and overall health.

References

  1. Ganguly, P., & Alam, S. F. (2015). Role of homocysteine in the development of cardiovascular disease. Nutrition Journal, 14, 6.[Link][PubMed][DOI]
  2. Chrysant, S. G., & Chrysant, G. S. (2018). The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Expert Review of Cardiovascular Therapy, 16(8), 559-565.[PubMed][DOI]
  3. Azzini, E., Ruggeri, S., & Polito, A. (2020). Homocysteine: Its Possible Emerging Role in At-Risk Population Groups. International Journal of Molecular Sciences, 21(4), 1421.[PubMed][DOI]
  4. Tinelli, C., Di Pino, A., Ficulle, E., Marcelli, S., & Feligioni, M. (2019). Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies. Frontiers in Nutrition, 6, 49.[PubMed][DOI]
  5. Kumar, A., Palfrey, H. A., Pathak, R., Kadowitz, P. J., Gettys, T. W., & Murthy, S. N. (2017). The metabolism and significance of homocysteine in nutrition and health. Nutrition & Metabolism, 14, 78.[PubMed][DOI]
  6. Djuric, D., Jakovljevic, V., Zivkovic, V., & Srejovic, I. (2018). Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems. Canadian Journal of Physiology and Pharmacology, 96(10), 991-1003.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my homocysteine at home?

You can test your homocysteine at home with SiPhox Health's Heart & Metabolic Program, which includes homocysteine testing along with other crucial cardiovascular biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is the optimal homocysteine level?

While normal ranges are typically 5-15 μmol/L, optimal levels for cardiovascular protection are below 10 μmol/L. Levels between 10-15 μmol/L are considered borderline, and anything above 15 μmol/L is elevated and requires intervention.

How quickly can homocysteine levels be lowered?

With proper B vitamin supplementation and dietary changes, homocysteine levels can often be reduced significantly within 6-12 weeks. However, the response varies based on the underlying cause and individual factors like genetics and absorption capacity.

Can high homocysteine be genetic?

Yes, genetic mutations, particularly in the MTHFR gene, can cause elevated homocysteine levels. Up to 40% of the population has at least one copy of the C677T mutation, which can impair the body's ability to process homocysteine efficiently.

What foods should I avoid with high homocysteine?

Limit alcohol consumption, which interferes with B vitamin metabolism, and reduce excessive coffee intake (more than 4 cups daily). Also minimize processed foods low in B vitamins and high in refined sugars, which can impair methylation processes.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details